Rosiglitazone Improves Insulin Sensitivity in Spontaneously Hypertensive-Rats

李榕,高峰,黄晨,张海锋,马恒,姬秋如

DOI: https://doi.org/10.3969/j.issn.1671-5403.2008.03.014

2008-01-01

Chinese Journal of Multiple Organ Diseases in the Elderly

Abstract:Objective To study the effect of rosiglitazone on hypertension,blood glucose and insulin levels in spontaneously hypertensive rats(SHR)and responsiveness of their isolated blood vessels to insulin.Methods Young and adult SHR were given rosiglitazone maleate 〔3 mg/(kg·d),n=12〕 for 2 weeks(treated SHR).Untreated young and adult SHR(n=18),young and adult Wistar-Kyoto rats(WKY)(n=31)were given diet alone.At the end of the study,systolic blood pressure,plasma glucose and insulin levels were measured,and insulin(with increasing doses from 1 to 120 U/L)-induced relaxation of norepinephrine(NE)-induced constriction was tested for isolated aortic rings with a myograph.Results Systolic blood pressure,plasma glucose and insulin levels were similar in untreated and treated adult SHR 〔(187±4)vs(181±5)mmHg,P0.05;(6.2±0.2)vs(5.3±0.3)mmol/L,P0.05;(23.8±3.7)vs(20.4±0.8)mU/L,P0.05〕.The vasodilation induced by insulin was impaired in untreated and treated adult SHR〔% of maximal contraction:(73±4)% vs(72±8)%〕and was different in adult WKY 〔(29±4)%,P0.01〕.However,this impairment was partially prevented by rosiglitazone in young SHR 〔treated young SHR(40±6)% vs untreated young SHR(61±5)%,P0.01〕.Conclusion Short-term administration of rosiglitazone fails to prevent the development of hypertension and lower plasma glucose and insulin levels.However,it improves insulin sensitivity in SHR,especially in young SHR.